tetano
Editor, Senior Moderator
Cureus
. 2021 Jan 30;13(1):e13004.
doi: 10.7759/cureus.13004.
Coronavirus Disease-Associated Pulmonary Aspergillosis: A Devastating Complication of COVID-19
Adeel Nasrullah[SUP] 1 [/SUP], Anam Javed[SUP] 1 [/SUP], Khalid Malik[SUP] 2 [/SUP]
Affiliations
Abstract
Coronavirus disease-19 (COVID-19) has affected more than ninety-three million people worldwide till January 2021. COVID-19 can cause a destructive dysregulated immune response which can result in numerous complications such as kidney failure, myocarditis, and strokes. A new entity called coronavirus disease-associated pulmonary aspergillosis (CAPA) has emerged in recent times. The literature on CAPA is limited. We present a case of CAPA in an immunocompetent patient who was placed on veno-venous extra-corporeal membranous oxygen (VV-ECMO). We briefly explained pathophysiology, clinical presentations, and management of CAPA in this report.
Keywords: corona virus disease 2019 (covid-19); immuno-competent; invasive aspergillosis; vv-ecmo.
. 2021 Jan 30;13(1):e13004.
doi: 10.7759/cureus.13004.
Coronavirus Disease-Associated Pulmonary Aspergillosis: A Devastating Complication of COVID-19
Adeel Nasrullah[SUP] 1 [/SUP], Anam Javed[SUP] 1 [/SUP], Khalid Malik[SUP] 2 [/SUP]
Affiliations
- PMID: 33659135
- PMCID: PMC7919614
- DOI: 10.7759/cureus.13004
Abstract
Coronavirus disease-19 (COVID-19) has affected more than ninety-three million people worldwide till January 2021. COVID-19 can cause a destructive dysregulated immune response which can result in numerous complications such as kidney failure, myocarditis, and strokes. A new entity called coronavirus disease-associated pulmonary aspergillosis (CAPA) has emerged in recent times. The literature on CAPA is limited. We present a case of CAPA in an immunocompetent patient who was placed on veno-venous extra-corporeal membranous oxygen (VV-ECMO). We briefly explained pathophysiology, clinical presentations, and management of CAPA in this report.
Keywords: corona virus disease 2019 (covid-19); immuno-competent; invasive aspergillosis; vv-ecmo.